277 related articles for article (PubMed ID: 29450487)
1. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
Tsimploulis A; Lam PH; Arundel C; Singh SN; Morgan CJ; Faselis C; Deedwania P; Butler J; Aronow WS; Yancy CW; Fonarow GC; Ahmed A
JAMA Cardiol; 2018 Apr; 3(4):288-297. PubMed ID: 29450487
[TBL] [Abstract][Full Text] [Related]
2. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Arundel C; Lam PH; Gill GS; Patel S; Panjrath G; Faselis C; White M; Morgan CJ; Allman RM; Aronow WS; Singh SN; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Jun; 73(24):3054-3063. PubMed ID: 31221253
[TBL] [Abstract][Full Text] [Related]
3. Heart Rate and Outcomes in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction.
Lam PH; Dooley DJ; Deedwania P; Singh SN; Bhatt DL; Morgan CJ; Butler J; Mohammed SF; Wu WC; Panjrath G; Zile MR; White M; Arundel C; Love TE; Blackman MR; Allman RM; Aronow WS; Anker SD; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2017 Oct; 70(15):1861-1871. PubMed ID: 28982499
[TBL] [Abstract][Full Text] [Related]
4. Systolic Blood Pressure and Outcomes in Older Patients with HFpEF and Hypertension.
Faselis C; Lam PH; Zile MR; Bhyan P; Tsimploulis A; Arundel C; Patel S; Kokkinos P; Deedwania P; Bhatt DL; Zeng-Trietler Q; Morgan CJ; Aronow WS; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2021 Apr; 134(4):e252-e263. PubMed ID: 33010225
[TBL] [Abstract][Full Text] [Related]
5. Digoxin Discontinuation and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction.
Malik A; Masson R; Singh S; Wu WC; Packer M; Pitt B; Waagstein F; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
J Am Coll Cardiol; 2019 Aug; 74(5):617-627. PubMed ID: 31370952
[TBL] [Abstract][Full Text] [Related]
6. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
[TBL] [Abstract][Full Text] [Related]
7. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
[TBL] [Abstract][Full Text] [Related]
8. Digoxin Initiation and Outcomes in Patients with Heart Failure with Preserved Ejection Fraction.
Lam PH; Packer M; Gill GS; Wu WC; Levy WC; Zile MR; Brar V; Arundel C; Cheng Y; Singh SN; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Oct; 133(10):1187-1194. PubMed ID: 32272101
[TBL] [Abstract][Full Text] [Related]
9. Factors Associated With and Prognostic Implications of Cardiac Troponin Elevation in Decompensated Heart Failure With Preserved Ejection Fraction: Findings From the American Heart Association Get With The Guidelines-Heart Failure Program.
Pandey A; Golwala H; Sheng S; DeVore AD; Hernandez AF; Bhatt DL; Heidenreich PA; Yancy CW; de Lemos JA; Fonarow GC
JAMA Cardiol; 2017 Feb; 2(2):136-145. PubMed ID: 28030747
[TBL] [Abstract][Full Text] [Related]
10. Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction.
Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
Int Heart J; 2019 Jul; 60(4):876-885. PubMed ID: 31257340
[TBL] [Abstract][Full Text] [Related]
11. Blood Pressure, Readmission, and Mortality Among Patients Hospitalized With Acute Kidney Injury.
Griffin BR; Vaughan-Sarrazin M; Shi Q; Ten Eyck P; Reisinger HS; Kennelty K; Good MK; Swee ML; Yamada M; Lund BC; Jalal DI
JAMA Netw Open; 2024 May; 7(5):e2410824. PubMed ID: 38739389
[TBL] [Abstract][Full Text] [Related]
12. Prior Heart Failure Hospitalization and Outcomes in Patients with Heart Failure with Preserved and Reduced Ejection Fraction.
Malik A; Gill GS; Lodhi FK; Tummala LS; Singh SN; Morgan CJ; Allman RM; Fonarow GC; Ahmed A
Am J Med; 2020 Jan; 133(1):84-94. PubMed ID: 31336093
[TBL] [Abstract][Full Text] [Related]
13. Initiation of anti-hypertensive drugs and outcomes in patients with heart failure with preserved ejection fraction and persistent hypertension.
Lam PH; Tsimploulis A; Patel S; Raman VK; Arundel C; Faselis C; Deedwania P; Sheikh FH; Banerjee SK; Allman RM; Fonarow GC; Aronow WS; Ahmed A
Prog Cardiovasc Dis; 2022; 73():17-23. PubMed ID: 35777433
[TBL] [Abstract][Full Text] [Related]
14. Beta-blocker Use and 30-day All-cause Readmission in Medicare Beneficiaries with Systolic Heart Failure.
Bhatia V; Bajaj NS; Sanam K; Hashim T; Morgan CJ; Prabhu SD; Fonarow GC; Deedwania P; Butler J; Carson P; Love TE; Kheirbek R; Aronow WS; Anker SD; Waagstein F; Fletcher R; Allman RM; Ahmed A
Am J Med; 2015 Jul; 128(7):715-21. PubMed ID: 25554369
[TBL] [Abstract][Full Text] [Related]
15. Systolic blood pressure at admission, clinical characteristics, and outcomes in patients hospitalized with acute heart failure.
Gheorghiade M; Abraham WT; Albert NM; Greenberg BH; O'Connor CM; She L; Stough WG; Yancy CW; Young JB; Fonarow GC;
JAMA; 2006 Nov; 296(18):2217-26. PubMed ID: 17090768
[TBL] [Abstract][Full Text] [Related]
16. Association between use of β-blockers and outcomes in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M; Friberg L
JAMA; 2014 Nov; 312(19):2008-18. PubMed ID: 25399276
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.
Li S; Li X
High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):405-412. PubMed ID: 28725953
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of systolic blood pressure in acute heart failure with preserved ejection fraction in older patients.
Putot S; Hacquin A; Manckoundia P; Putot A
ESC Heart Fail; 2021 Dec; 8(6):5493-5500. PubMed ID: 34664426
[TBL] [Abstract][Full Text] [Related]
19. Association between use of renin-angiotensin system antagonists and mortality in patients with heart failure and preserved ejection fraction.
Lund LH; Benson L; Dahlström U; Edner M
JAMA; 2012 Nov; 308(20):2108-17. PubMed ID: 23188027
[TBL] [Abstract][Full Text] [Related]
20. Association of Mineralocorticoid Receptor Antagonist Use With All-Cause Mortality and Hospital Readmission in Older Adults With Acute Decompensated Heart Failure.
Yaku H; Kato T; Morimoto T; Inuzuka Y; Tamaki Y; Ozasa N; Yamamoto E; Yoshikawa Y; Kitai T; Taniguchi R; Iguchi M; Kato M; Takahashi M; Jinnai T; Ikeda T; Nagao K; Kawai T; Komasa A; Nishikawa R; Kawase Y; Morinaga T; Toyofuku M; Seko Y; Furukawa Y; Nakagawa Y; Ando K; Kadota K; Shizuta S; Ono K; Sato Y; Kuwahara K; Kimura T;
JAMA Netw Open; 2019 Jun; 2(6):e195892. PubMed ID: 31225889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
